Pyxis Oncology, Inc. Area of Real Estate Property
Pyxis Oncology, Inc. (PYXS) had Area of Real Estate Property of 17.73 thousand sqft as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:AreaOfRealEstateProperty · last filed 2026-08-13
- 2026-06-30: Area of Real Estate Property 17.73K sqft.
- 2026-03-31: Area of Real Estate Property 17.73K sqft.
- 2025-09-30: Area of Real Estate Property 17.73K sqft.
- 2025-06-30: Area of Real Estate Property 17.73K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2026-06-30 | 17.73K sqft 10-Q · filed 2026-08-13 |
| 2026-03-31 | 17.73K sqft 10-Q · filed 2026-05-14 |
| 2025-09-30 | 17.73K sqft 10-Q · filed 2025-11-03 |
| 2025-06-30 | 17.73K sqft 10-Q · filed 2025-08-14 |
| 2025-03-31 | 17.73K sqft 10-Q · filed 2025-05-15 |
| 2023-02-02 | 17.73K sqft 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |